Skip Navigation Links
ScientificNameLabel
Ergosta-7,24(28)-dien-3beta-ol
PHCD compound ID : 4669
Chemical Names :
Ergosta-7,24(28)-dien-3beta-ol
Molecular Formula : C28H46O1
Molecular Weight : 398.354866
More Details :
Names & Synonyms: (3S,5S,10S,13R,14R,17R)-17-[(1R)-1,5-dimethyl-4-methylene-hexyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol , (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methyleneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol , (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol , (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylidene-heptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol , (3S,5S,10S,13R,14R,17R)-17-[(1R)-4-isopropyl-1-methyl-pent-4-enyl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
Smiles: O[C@H]1CC[C@]2([C@H](C1)CC=C1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=C)C(C)C)C)C)C
InChi : InChI=1S/C28H46O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h10,18,20-22,24-26,29H,3,7-9,11-17H2,1-2,4-6H3/t20-,21+,22+,24-,25+,26+,27+,28-/m1/s1
InChi Key : InChIKey=BTCAEOLDEYPGGE-JVAZTMFWSA-N
PubChem ID : 23724571
Rotatable bond count : 5 Rule of five : 1
Hydrogen bond acceptor count : 1 Ionization potential : 9.101367
Hydrogen bond donor count : 1 Electric dipole moment : 2.664
XLogP : 10.295 VDW volume : 446.935503
Molecular weight : 398.354866 HOMO-LUMO gap : 10.359000
Herb list :
Refrences & Litretures:
  
741.      Journal:'Journal of the American Oil Chemists' Society'      Year:'1998'      Volume:'75'      Page:'51'      DOI:'10.1007/s11746-998-0009-8'      Title:'4-Demethylsterols and Triterpene Alcohols from Two Vanilla Bean Species: Vanilla fragrans and V. tahitensis'
Copyright © 2017, Chemistry and Chemical Engineering Research Center of Iran. All rights reserved.
Follow us